论文信息 - Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial - 字舞流文

Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial

N. Kemeny | A. Cercek | T. Bekaii-Saab | D. Niedzwiecki | T. Zemla | F. Ou | Christina Wu | K. Ng | J. Strickler | J. Hubbard | B. Jaszewski | P. Boland | F. Sanchez | Lorelei Bandel | B. Schweitzer | Lorelei A. Bandel